Advancing the understanding of Lynch Syndrome screening and the significance of comprehensive genetic testing

Mev Dominquez-Valentin from the Department of Tumor Biology at the Institute for Cancer Research is senior author on a study recently published in the prestigious journal Clinical Gastroenterology and Hepatology, entitled: "Characterization of Screening Strategies for Lynch Syndrome in Latin America.” The study involves the collaborations of more than 50 investigators from 24 representative genetic cancer registries/center of 8 countries from Latin America, highlighting the significant insights we've gained into Lynch Syndrome (LS) screening methods across the region. The results emphasize challenges in hereditary cancer syndrome screening in Latin America and the need for enhanced strategies. Other OUS researchers involved in the study are Eivind Hovig, Pål Møller and Vessela Kristensen.

Mev Dominquez Valentin

 

Links:

The Clinical Gastroenterology and Hepatology article:
Characterization of screening strategies for Lynch syndrome in Latin America.
Campos-Segura AV, ... Dominguez-Valentin M; LA-GETH..
Clin Gastroenterol Hepatol. 2025 Feb 24:S1542-3565(25)00145-4.
doi: 10.1016/j.cgh.2024.12.026.  PMID: 40010418.

Inherited and Familial Cancer Project Group - led by Mev Dominquez Valentin

Department of Tumor Biology

Institute for Cancer Research

Previos news articles about Mev Dominquez-Valentin:

Dr Ragnar Mørk´s Prize for Excellent Cancer Research 2023 to Mev Dominguez-Valentin

Groundbreaking Study Identifies Six New Cancer Susceptibility Genes

Germline biomarkers for clinical management of sporadic and familiar tumors

Publication in ClinicalMedicine, part of The Lancet Discovery Science: Mev Dominguez-Valentin published about the low colorectal cancer mortality in Lynch syndrome (LS) individuals